3D-QSAR Studies of 8-Substituted-2-aryl-5-alkylaminoquinolines as Corticotropin-releasing Factor-1 Receptor Antagonists

목차 (Table of Contents)

• Abstract
• 1. Introduction
• 2. Computational Methods
• 2.1. Data Set
• 2.2. Ligand-based Alignment Method
• 2.3. CoMFA Field Generation
• 2.4. Partial Least Square (PLS) Analysis
• 3. Results and Discussion
• 3.1. CoMFA Analysis
• 3.2. CoMFA Contour Map
• 4. Conclusion
• References

참고문헌 (Reference)

1 E. M. Jutkiewicz, "The effects of CRF antagonists, antalarmin, CP154, 526, LWH234, and R121919, in the forced swim test and on swiminduced increases in adrenocorticotropin in rats" 180 : 215-223, 2005

2 K. Takeda, "Synthesis and structure–activity relationships of 8-substituted-2-aryl-5-alkylaminoquinolines : Potent, orally active corticotropin-releasing factor-1 receptor antagonists" 20 : 6559-6578, 2012

3 U. Debnath, "Pyridones as NNRTIs against HIV-1 mutants : 3D-QSAR and protein informatics" 27 : 637-654, 2013

4 S. Wold, "PLSregression : a basic tool of chemometrics" 58 : 109-130, 2001

5 V. Coric, "Multicenter, randomized, doubleblind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1antagonist in generalized anxiety disorder" 27 : 417-425, 2010

6 R. L. Hauger, "International union of pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands" 55 : 21-26, 2003

7 N. Sato, "Immunolocalization of corticotropin-releasing Hormone(CRH)and its receptors(CRHR1 and CRHR2)in human endometrial carcinoma : CRHR1 as a potent prognostic factor" 24 : 1549-1557, 2014

8 D. Fernández, "Human farnesyl pyrophosphate synthase inhibition by nitrogen bisphosphonates : A 3D-QSAR study" 27 : 739-754, 2013

9 S. J. Cho, "Cross-validated R2-guided region selection for comparative molecular field analysis : A simple method to achieve consistent results" 37 : 1060-1066, 1995

10 F. C. Raadsheer, "Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with alzheimer's disease and depression" 152 : 1372-1376, 1995

11 F. Stamatelou, "Corticotropin-releasing hormone and progesterone plasma levels association with the onset and progression of labor" 40 : 568-571, 2013

12 R. Pastor, "Corticotropin-releasing factor-1 receptor involvement in behavioral neuroadaptation to ethanol : A urocortin1-independent mechanism" 105 : 9070-9075, 2008

13 H. -B. Fan, "Corticotropin-releasing factor mediates bone cancer induced pain through neuronal activation in rat spinal cord" 1-7, 2015

14 B. P. Grone, "A second corticotropin-releasing hormone gene(CRH2)is conserved across vertebrate classes and expressed in the hindbrain of a basal neopterygian fish, the spotted gar" 523 : 1125-1143, 2015

15 B. Binneman, "A 6-week randomized, placebo-controlled trial of CP-316, 311(a selective CRH1 antagonist)in the treatment of major depression" 165 : 617-620, 2008